Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma Active Not Recruiting Phase 1 / 2 Trials for Gemcitabine (DB00441)

IndicationStatusPhase
DBCOND0031894 (Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma)Active Not Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01535924Gemcitabine and Bendamustine in Patients With Relapsed or Refractory Hodgkin's LymphomaTreatment